Description
Scope of the Report The report titled “ Global Biosimilar Market : Trends & Opportunities ( 2015 Edition )” analyzes the global biologics market , with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs . The key market challenges recognized by the analysts and the major trends biosimilar market are presented in the report . Further , key manufacturers of Biosimilars like Sandoz , Teva , Hospira and Dr . Reddy ’ s Lab are profiled in the report .
Purchase a copy of Global Biosimilar Market visit @ http :// www . orbisresearch . com / contact / purchase / 185270 For more information contact sales @ orbisresearch . com .
Product Coverage Recombinant Glycosylated Biosimilars ( EPO , mAb , Follitropin ) Humira , Enbrel , Remicade , Herceptin Recombinant Non-Glycosylated Biosimilars ( Insulin , G-csf , Interferons , hGh )
Company Coverage Sandoz ( Novartis ) Hospira Teva Dr . Reddy ’ s Lab
Executive Summary Rising budgetary pressures to reduce healthcare expenditures , patent expiries of blockbuster drugs , growing demand for cost-effective alternatives , increasing aging population , conductive government initiatives and rising incidences of various diseases are significant factors that are responsible for the growth of global biosimilar market ( 2013 to 2018 ). On the other hand stringent regulatory environment in some countries , high manufacturing complexities , costs , and presence of low priced generic drugs and high-entry barriers are considered to hinder the market growth . Emerging pharmaceutical market and less stringent government regulatory frameworks in few countries can provides some of the major opportunities for biosimilars market . In addition , increased collaboration between manufacturing companies and outsourcing of biosimilar products are key trends for biosimilars market .
Request a sample of this report @ http :// www . orbisresearch . com / contacts / request-sample / 185270 .
The biosimilar products market is segmented into recombinant non-glycosylated proteins , recombinant glycosylated proteins , and recombinant peptides . Globally there are 280 biosimilars in pipeline and their clinical trials are increasing at a rate of 20 % annually .
The report titled “ The Global Biosimilar Market : Trends & Opportunities ( 2014-2018 )” provides an indepth analysis of the growing Biosimilar Market with detailed analysis of market sizing and growth , market share and economic impact of the industry . The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry . Growth of the
www . orbisresearch . com ; + 1 ( 214 ) 884-6817 ; + 9120-64101019